Annual accounts & ratios
Source: NBB · 2024How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €1.50M |
| Net profit | €675k |
| Cash flow | €1.24M |
| Staff costs | €293k |
| Income taxes | €96k |
| Dividends | — |
| Total assets | €10.25M |
| Equity | €798k |
| Debt | €9.45M |
| of which ≤ 1y | €1.34M |
| of which > 1y | €8.11M |
| Working capital | €-562k |
| Employees (FTE) | 4.0 |
| 2024 | |
|---|---|
| Current ratio | 0.58 |
| Quick ratio | 0.58 |
| Working capital ratio | -5.5% |
| Solvency | 7.8% |
| Debt / equity | 11.85 |
| Long-term debt ratio | 10.17 |
| Interest coverage | 8.92 |
| Gross margin | — |
| Net margin | — |
| ROA | 6.6% |
| ROE | 84.6% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €10.25M |
| Fixed assets | 21/28 | €9.47M |
| Formation expenses | 20 | €0 |
| Tangible fixed assets | 22/27 | €9.47M |
| Current assets | 29/58 | €777k |
| Amounts receivable within one year | 40/41 | €474k |
| Investments | 50/53 | €60k |
| Cash & bank | 54/58 | €243k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €10.25M |
| Equity | 10/15 | €798k |
| Contributions / capital | 10/11 | €30k |
| Accumulated profits (losses) | 14 | €768k |
| Amounts payable | 17/49 | €9.45M |
| Amounts payable after one year | 17 | €8.11M |
| Amounts payable within one year | 42/48 | €1.34M |
| Trade debts payable within one year | 44 | €6k |
| Income statement | ||
| Gross operating margin | 9900 | €1.80M |
| Operating result | 9901 | €940k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €168k |
| Result before taxes | 9903 | €771k |
| Income taxes | 67/77 | €96k |
| Net result for the period | 9904 | €675k |
| Result to be appropriated | 9905 | €675k |
Health barometer
FY 2024 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →